Prior treatments—including idebenone, NAD+, and hormone replacement therapy (HRT)—failed to show efficacy in this LHON-affected case (m.11778G>a/MT-ND4). This evidence concerns the gene MT-ND4 and Leber hereditary optic neuropathy.